Maiwald Magazine

News and Releases

Maiwald Blog

Equivalent infringement in different European jurisdictions

As part of our regular internal legal seminars, Dr. Wilhelm Eger held a talk on current developments in infringement under the doctrine of equivalency in various European lega...

Continue reading

Implementation of the Pharmaceutical Strategy for Europe and the Intellectual Property Action Plan – Part 3

In addition to the pharmaceutical strategy for Europe[1], the European Commission adopted a new action plan for intellectual prop...

Continue reading

Implementation of the Pharmaceutical Strategy for Europe and the Intellectual Property Action Plan – Part 2

In addition to the Pharmaceutical strategy for Europe[1], the European Commission adopted a new Action Plan for Intellectual Prop...

Continue reading

All articles

Press Coverage

PI decision at UPC local division Munich after withdrawal of the PI request

The article sheds light on preliminary injunction proceedings before the local division of the Unified Patent Court (UPC) in Munich between the applicant Tiroler Rohre (TRM) and the defendants SSAB Swedish Steel GmbH and SSAB Europe Oy concerning pile shoes for anchoring str...

Continue reading

Sanofi cabazitaxel patent revoked by Paris court

In the ongoing case between Sanofi and the generic drug manufacturer Accord, the Paris Judicial Court has fully revoked Sanofi’s patent for the chemotherapy drug Jevtana. The patent EP 2 493 466, which protects a new use of cabazitaxel in combination with prednisone or pre...

Continue reading

Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline

Deal provides Cytokinetics with diversified access to capital as company advances its specialty cardiology franchise NEW YORK, NY and SOUTH SAN FRANCISCO, CA, May 22, 2024 – Royalty Phar...

Continue reading

Maiwald in the press

Staff News

Maiwald congratulates on passing the exam

We would like to congratulate

Continue reading

Dr. Gisela Gerstberger appointed partner at Maiwald

Maiwald, one of Germany's leading intellectual property law firms, has appointed Dr. Gisela Gerstberger as partner with effect from October 1, 2024, thereby expanding its grow...

Continue reading

Maiwald Congratulates on Passing the EQE Examination

We are very pleased to congratulate 

Continue reading

Staff News

Publications

Interview IAM Strategy 300 Global Leaders, 2024

This year, IAM has once again invited leading experts in the field of intellectual property to provide valuable insights, highlight key experiences and share their views on th...

Continue reading

EU pharmaceutical reforms propose changes to regulatory protection periods, Managing IP 2024

Dr. Christian Meyer and Dr. Gisela Grabow discuss potential changes to the EU pharmaceutical regulation and their possible impact on data and market protection timelines for m...

Continue reading

Year Two – The Unitary Patent and the Unified Patent Court at a Glance, AIPLA Chemical Practice Chronicles Newsletter, Vol. 12 Issue 2, 2024

We can now look back on a quite successful first year of the new European patent and court system. Now well into its second year, the Unitary Patent (UP) continues to grow in ...

Continue reading

All publications

Awards

Maiwald awarded 1st place by FOCUS as top employer for medium-sized companies in 2025

At Maiwald, we go to great lengths to ensure that all our colleagues feel comfortable and are constantly trying to optimize ourselves in order to achieve and maintain the most...

Continue reading

IAM Strategy 300 Global Leaders 2025

We are delightet that IAM has recognized eight of our partners as Strategy 300 Global Leaders: Dr. Andreas Ledl...

Continue reading

JUVE Patent Rankings Germany 2024

JUVE Patent published the new JUVE Patent Germany ranking 2024 – and our firm is not only recommended in the category “Patent Filing” but also in “

Continue reading

All awards

Events

Pharma & Biotech Patent Litigation Europe 2025 in Amsterdam

We're excited to be a Platinum Partner to the 4th Annual Pharma & Biotech Patent Litigation Europe! Don't miss the Co-Chairs' Opening Remarks with our partner

Continue reading

PatentFORUM conference 2024

as part of the 44th Patent and Trademark FORUM 2024 The PatentFORUM is your opportunity to exchange ideas with your colleagues at a high level and to keep up to date with the latest developments in patent law.

Continue reading

14th PAFA Conference from 27-29 November in Augsburg by IP for IP – a must for every IP professional!

The conference will once again offer IP professionals a top-class programme - with more than twenty lecturers and specialist topics, a balanced combination of workshops and lectures on the latest developments and case law in national and international patent, trademark and design law. Our colleague

Continue reading

Webinar: SPC Manufacturing & Stockpiling Waiver: Legal requirements, opportunities and risks of the SPC Waiver – Regulation (EU) 2019/933

During this webinar, we will discuss key aspects of the SPC Waiver Regulation while referring to recent case law in the Netherlands and Germany: - Scope of Application of the SPC Waiver - Obligations for the Generics and Biosimilar Companies - The Court Decisions in the Hague and Munich

Continue reading

All events